Perrigo Company plc
NYSE:PRGODrug Manufacturers - Specialty & Generic
-$0.20 today
- Market cap
- $2.35B
- Beta
- 0.52
- P/E (TTM)
- -0.8
- EPS (TTM)
- -$13.10
- Dividend yield
- 11.65%
Volume 2.57M
Average 2.96M
PRGO Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
Perrigo Company plcNYSE: PRGO
Depreciation & Amortization · Q2 FY2026 · quarter ended Jun 2026
Depreciation & amortization growth accelerates
Q2 FY2026 depreciation & amortization of $179.1M rose 107.5% year over year, ahead of the +22.7% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 115.0% from the prior quarter. Over 3 fiscal years it compounded at -0.1% a year.
Context
- Depreciation & amortization amounted to 7.9% of revenue in FY2025, up 0.5 pp from a year earlier.
- Depreciation & amortization increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +107.5% holds above the trailing-twelve-month pace of +22.7%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 337.5M USD
- Year-over-year change
- +3.6%
- 4-year CAGR
- +2.0%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 337.5M | +3.6% |
| FY2024 | 2024-12-31 | 325.9M | -9.3% |
| FY2023 | 2023-12-31 | 359.5M | +6.2% |
| FY2022 | 2022-12-31 | 338.6M | +8.5% |
| FY2021 | 2021-12-31 | 312.2M | — |
Depreciation & Amortization vs competitors
How PRGO compares with its peers on the latest reported figures
- PRGO's LTM Jun 2026 depreciation & amortization of $403.5M is the 2nd highest of the 10 companies compared; the peer median is $48.5M.
- Its year-over-year change of +22.7% is the 2nd highest of 10, against a peer median of -4.4%.
- Depreciation & amortization amounts to 9.7% of revenue for PRGO, versus a peer median of 5.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.17B | -5.6% | -4.7% | 10.8% | |
| LTM Jun 2026 | $403.5M | +22.7% | -0.1% | 9.7% | |
| LTM Sep 2026 | $177.3M | +18.2% | +15.3% | 5.3% | |
| LTM Jun 2026 | $101.71M | +26.1% | +2.3% | 12.2% | |
| LTM Mar 2026 | $81.84M | -4.4% | +23.4% | 10.4% | |
| LTM Sep 2026 | $48.5M | -15.7% | -10.1% | 3.2% | |
| LTM Jun 2025 | $12.21M | +14.7% | +15.5% | 2.0% | |
HTFLHeartflow, Inc. Common Stock | LTM Sep 2026 | $6.94M | -19.8% | — | 2.9% |
| LTM Sep 2026 | $1.88M | +7.7% | +77.3% | 0.3% | |
| LTM Sep 2026 | $1.32M | -19.2% | -17.8% | 230.7% | |
| Peer median (excluding PRGO) | $48.5M | -4.4% | +8.8% | 5.3% | |
Competitors are the stored peer set for PRGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 4.14B | 4.45B | 4.66B | 4.37B | 4.25B |
| Cost of Revenue | 2.72B | 3B | 2.98B | 2.83B | 2.76B |
| Gross Profit | 1.42B | 1.46B | 1.68B | 1.54B | 1.49B |
| Gross Margin | 34.2% | 32.7% | 36.1% | 35.3% | 35.1% |
| Research & Development | 122M | 123.1M | 122.5M | 112.2M | 95.4M |
| Selling, General & Admin | 1.11B | 1.21B | 1.27B | 1.11B | 526.5M |
| Operating Expenses | 1.01B | 1.38B | 1.53B | 1.43B | 1.15B |
| Depreciation & Amortization | 312.2M | 338.6M | 359.5M | 325.9M | 337.5M |
| EBITDA | 695.9M | 355.5M | 525M | 433M | (797.9M) |
| EBITDA Margin | 16.8% | 8.0% | 11.3% | 9.9% | -18.8% |
| Operating Income | 410.4M | 78.9M | 151.9M | 112.9M | 343.3M |
| Operating Margin | 9.9% | 1.8% | 3.3% | 2.6% | 8.1% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 125M | 156M | 173.8M | 187.8M | 162.5M |
| Other Income / Expenses | (151.7M) | (218M) | (160.2M) | (193.6M) | (1.64B) |
| Income Before Tax | 258.7M | (139.1M) | (8.3M) | (80.7M) | (1.3B) |
| Pre-Tax Margin | 6.3% | -3.1% | -0.2% | -1.8% | -30.5% |
| Income Tax Expense | 389.6M | (8.2M) | (3.9M) | 80M | 104.4M |
| Net Income | (68.9M) | (140.6M) | (12.7M) | (171.8M) | (1.43B) |
| Net Margin | -1.7% | -3.2% | -0.3% | -3.9% | -33.5% |
| EPS (Basic) | (0.98) | (0.97) | (0.09) | (1.25) | (10.29) |
| EPS (Diluted) | (0.98) | (0.97) | (0.09) | (1.25) | (10.29) |
| Weighted Avg Shares | 133.6M | 134.5M | 135.3M | 137.4M | 138.5M |
| Weighted Avg Shares (Diluted) | 133.6M | 134.5M | 135.3M | 137.4M | 138.5M |
Perrigo Company plc
NYSE:PRGO
Intrinsic Alpha fair value
Locked
Current Price
$16.94
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.